Clinical Evaluation of GENEX® DS in Instrumented Posterolateral Fusion



Status:Terminated
Conditions:Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:18 - 75
Updated:4/21/2018
Start Date:December 2014
End Date:December 2016

Use our guide to learn which trials are right for you!

CLINICAL EVALUATION OF GENEX® DS IN INSTRUMENTED POSTEROLATERAL FUSION

The overall goal of this clinical study is to characterize the fusion rate of geneX® ds bone
graft substitute in comparison to autograft, which is considered the gold standard for
posterolateral fusion. Assessments are made using AP and Lateral x-rays, F/E x-rays, and CT
scans geneX® ds has been cleared by the FDA for use in these procedures; however this study
will allow more detailed characterization of geneX® ds performance in the long-term (1 year).
By using the patient as their own control, direct comparison to autograft can be performed
while minimizing other variables.


Inclusion Criteria:

- Men or women 18-75 years of age

- Have ability to understand the requirements of the study, to provide written informed
consent, and to comply with the study protocol

- Have a spinal condition of the lumbar spine (L1-S1) requiring instrumented
posterolateral fusion at one or two levels

Exclusion Criteria:

- Patients undergoing instrumented fusion for trauma, tumor, psuedoarthrosis, or same- -
level recurrent stenosis

- Patients where placing graft material on both sides (posterolateral gutters) is not
possible, for example in the case of a complete facetectomy

- Patients requiring instrumented fusion in the cervical or thoracic spine

- Extraspinal cause of back pain such as trauma, infection, instrumentation failure, or
neoplasm

- Severe degenerative bone disease

- Hypercalcemia

- Active local or systemic infection

- Morbid obesity defined as BMI > 40

- Patients who are pregnant / able to become pregnant and not following a reliable
contraceptive method

- Uncooperative patients who can't or won't follow post-operative instructions including
individuals who abuse drugs or alcohol

- Anatomy or other factors that prohibit safe surgical access to the surgical site

- Allergy or sensitivity to any component of the treatment procedure

- Inadequate tissue coverage over the operative site

- Inadequate bone stock or bone quality

- Fever or leukocytosis

- Uncorrectable coagulopathy or hemorrhagic diathesis

- Uncontrolled diabetes

- Severe vascular disease or cardiopulmonary conditions that present prohibitive
anesthesia risk

- Neuromuscular disease or disorder

- Mental illness

- Has an active workman's compensation lawsuit
We found this trial at
2
sites
Charlotte, North Carolina 28204
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
535 E 70th St
New York, New York 10021
(212) 606-1000
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
?
mi
from
New York, NY
Click here to add this to my saved trials